A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to peyronie's disease

Journal of Sexual Medicine

Volumn 7, Issue 4 PART 1, 2010, Pages 1529-1537

  Rhoden, Ernani Luis ^a,b   Riedner, Charles Edison ^c   Fuchs, Sandra ^a   Ribeiro, Eduardo Porto ^a   Halmenschlager, Graziele ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c Hospital Militar de Porto Alegre Serviço de Urologia   (Brazil)

Author keywords

Associated Factor; Comorbidities in Peyronies Disease; Dyslipidemia; Erectile Dysfunction; Obesity; Peyronie's Disease

Indexed keywords

ANDROGEN; GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN; PRASTERONE SULFATE; TESTOSTERONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DUPUYTREN CONTRACTURE; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OBESITY; PEYRONIE DISEASE; PRIORITY JOURNAL; SMOKING; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 77955242665     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01584.x     Document Type: Article

References (25)

1. Chevallier D, Benizri E, Volpe P, Amiel J, Toubol J. La Peyronie disease. Historical, epidemiological, physiopathological data. Diagnostic and therapeutic approaches. Rev Med Interne 1997, 18(1):41s-45s. suppl
2. Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodosio da Ros C, Ary Vargas Souto C. Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 2001, 13:291-3.
3. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001, 88:727-30.
4. Smith CJ, McMahon C, Shabsigh R. Peyronie's disease: The epidemiology, aetiology and clinical evaluation of deformity. BJU Int 2005, 95:729-32.
5. Hellstrom WJ, Bivalacqua TJ. Peyronie's disease: Etiology, medical, and surgical therapy. J Androl 2000, 21:347-54.
6. Agrawal V, Ellins E, Donald A, Minhas S, Halcox J, Ralph DJ. Systemic vascular endothelial dysfunction in Peyronie's disease. J Sex Med 2008, 5:2688-93.
7. Usta MF, Bivalacqua TJ, Jabren GW, Myers L, Sanabria J, Sikka SC, Hellstrom WJ. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease. J Urol 2004, 171:775-9.
8. Jarow JP, Lowe FC. Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction. J Urol 1997, 158:1388-90.
9. Gholami SS, Lue TF. Peyronie's disease. Urol Clin North Am 2001, 28:377-90.
10. Bjekic MD, Vlajinac HD, Sipetic SB, Marinkovic JM. Risk factors for Peyronie's disease: A case-control study. BJU Int 2006, 97:570-4.
11. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinley JB. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Prev Med 2000, 30:328-38.
12. Mulhall JP. Expanding the paradigm for plaque development in Peyronie's disease. Int J Impot Res 2003, 15(5):S93-102. suppl
13. Zimmermann RP, Feil G, Bock C, Hoeltl L, Stenzl A. Significant alterations of serum cytokine levels in patients with Peyronie's disease. Int Braz J Urol 2008, 34:66-66. discussion
14. Somers KD, Dawson DM. Fibrin deposition in Peyronie's disease plaque. J Urol 1997, 157:311-5.
15. Ralph DJ, Minhas S. The management of Peyronie's disease. BJU Int 2004, 93:208-15.
16. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie's disease. J Urol 2002, 168:1075-9.
17. El-Sakka AI, Tayeb KA. Vascular impairment of erection in patients with diabetes and Peyronie's disease: Is that accumulative? J Sex Med 2009, 6:1736-42.
18. Deveci S, Hopps CV, O'Brien K, Parker M, Guhring P, Mulhall JP. Defining the clinical characteristics of Peyronie's disease in young men. J Sex Med 2007, 4:485-90.
19. Moreno SA, Morgentaler A. Testosterone deficiency and Peyronie's disease: Pilot data suggesting a significant relationship. J Sex Med 2009, 6:1729-35.
20. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, Natali A, Vaggi L, Catuogno C, Giustini M, Taggi F. Peyronie's disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol 2001, 40:525-30. SIMONA Study Group
21. Bell DS. Peyronie disease in association with carvedilol: A case report. South Med J 2008, 101:1157-8.
22. Sullivan ME, Keoghane SR, Miller MA. Vascular risk factors and erectile dysfunction. BJU Int 2001, 87:838-45.
23. Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R. The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction. Int J Impot Res 2007, 19:213-7.
24. El-Sakka AI. Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol 2006, 49:564-9.
25. Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004, 64:399-404.